{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:59:35Z","timestamp":1791201575706,"version":"4.2.0"},"reference-count":20,"publisher":"American Diabetes Association","issue":"2","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,2,1]]},"abstract":"<jats:p>Leptin, a hormone secreted by adipose tissue, acts to inhibit appetite and promote metabolism, thereby reducing body weight. Leptin also increases sympathetic activity and arterial pressure. Several murine models of obesity, including agouti obese mice, exhibit resistance to the anorexic and weight-reducing effects of leptin. Hypertension in agouti mice has been attributed to hyperleptinemia. These observations pose a seeming paradox. If these mice are leptin-resistant, then how can leptin contribute to hypertension? We tested the novel hypothesis that these mice have selective leptin resistance, with preservation of the sympathoexcitatory action despite resistance to the weight-reducing actions. Leptin-induced decreases in food intake and body weight were less in agouti obese mice than in lean littermates. In contrast, leptin-induced increases in sympathetic nerve activity did not differ in obese and lean mice. These findings support the concept of selective leptin resistance, with resistance to the metabolic actions of leptin but preservation of the sympathoexcitatory actions. This finding may have potential implications for human obesity, which is associated with elevated plasma leptin and is thought to be a leptin-resistant state. If leptin resistance is selective in obese humans, then leptin could contribute to sympathetic overactivity and its adverse consequences in human obesity.<\/jats:p>","DOI":"10.2337\/diabetes.51.2.439","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T19:04:22Z","timestamp":1173207862000},"page":"439-442","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":174,"title":["The Concept of Selective Leptin Resistance"],"prefix":"10.2337","volume":"51","author":[{"given":"Marcelo L.G.","family":"Correia","sequence":"first","affiliation":[{"name":"From the Hypertension Genetics Specialized Center of Research and Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, Iowa; and the Veterans Administration Medical Center, Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Haynes","sequence":"additional","affiliation":[{"name":"From the Hypertension Genetics Specialized Center of Research and Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, Iowa; and the Veterans Administration Medical Center, Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Rahmouni","sequence":"additional","affiliation":[{"name":"From the Hypertension Genetics Specialized Center of Research and Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, Iowa; and the Veterans Administration Medical Center, Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald A.","family":"Morgan","sequence":"additional","affiliation":[{"name":"From the Hypertension Genetics Specialized Center of Research and Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, Iowa; and the Veterans Administration Medical Center, Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William I.","family":"Sivitz","sequence":"additional","affiliation":[{"name":"From the Hypertension Genetics Specialized Center of Research and Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, Iowa; and the Veterans Administration Medical Center, Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyn L.","family":"Mark","sequence":"additional","affiliation":[{"name":"From the Hypertension Genetics Specialized Center of Research and Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, Iowa; and the Veterans Administration Medical Center, Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031223301495300_R1","doi-asserted-by":"crossref","unstructured":"Zhang Y, Proenca R, Maffel M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature\u2008372: 425\u2013432, 1994","DOI":"10.1038\/372425a0"},{"key":"2022031223301495300_R2","doi-asserted-by":"crossref","unstructured":"Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman, JM: Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci U S A\u200894:8878\u20138883, 1997","DOI":"10.1073\/pnas.94.16.8878"},{"key":"2022031223301495300_R3","doi-asserted-by":"crossref","unstructured":"Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI: Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest\u2008100:270\u2013278, 1997","DOI":"10.1172\/JCI119532"},{"key":"2022031223301495300_R4","doi-asserted-by":"crossref","unstructured":"Shek EW, Brands MW, Hall JE: Chronic leptin infusion increases arterial pressure. Hypertension\u200831:409\u2013414, 1998","DOI":"10.1161\/01.HYP.31.1.409"},{"key":"2022031223301495300_R5","doi-asserted-by":"crossref","unstructured":"Aizawa-Abe M, Ogawa Y, Masuzaki H, Ebihara K, Satoh N, Iwai H, Matsuoka N, Hayashi T, Hosoda K, Inoue G, Yoshimasa Y, Nakao K: Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest\u2008105:1243\u20131252, 2000","DOI":"10.1172\/JCI8341"},{"key":"2022031223301495300_R6","doi-asserted-by":"crossref","unstructured":"Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD: Role of melanocrotinergic neurons in feeding and the agouti obesity syndrome. Nature\u2008385:165\u2013168, 1997","DOI":"10.1038\/385165a0"},{"key":"2022031223301495300_R7","doi-asserted-by":"crossref","unstructured":"Cone RD: The central melanocortin system and energy homeostasis. Trends Endocrinol Metab\u200810:211\u2013216, 1999","DOI":"10.1016\/S1043-2760(99)00153-8"},{"key":"2022031223301495300_R8","doi-asserted-by":"crossref","unstructured":"Lu D, Willard D, Patel IR, Kadwell S, Overton L, Kost T, Luther M, Chen W, Woychik RP, Wilkison WO, Cone RD: Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature\u2008371:799\u2013802, 1994","DOI":"10.1038\/371799a0"},{"key":"2022031223301495300_R9","doi-asserted-by":"crossref","unstructured":"Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F: Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell\u200888:131\u2013141, 1997","DOI":"10.1016\/S0092-8674(00)81865-6"},{"key":"2022031223301495300_R10","doi-asserted-by":"crossref","unstructured":"Mark AL, Shaffer RA, Correia MLG, Morgan DA, Haynes WG: Contrasting blood pressure effects of obesity in leptin-deficient ob\/ob mice and agouti yellow obese mice. J Hypertens\u200817:1949\u20131953, 1999","DOI":"10.1097\/00004872-199917121-00026"},{"key":"2022031223301495300_R11","doi-asserted-by":"crossref","unstructured":"Haynes WG: Interaction between leptin and sympathetic nervous system in hypertension. Curr Hypertens Rep\u20082:311\u2013314, 2000","DOI":"10.1007\/s11906-000-0015-1"},{"key":"2022031223301495300_R12","doi-asserted-by":"crossref","unstructured":"Niijima A: Afferent signals from leptin sensors in the white adipose tissue of the epididymis, and their reflex effect in the rat. J Auton Nerv Syst\u200873:19\u201325, 1998","DOI":"10.1016\/S0165-1838(98)00109-X"},{"key":"2022031223301495300_R13","doi-asserted-by":"crossref","unstructured":"Niijima A: Reflex effects from leptin sensors in the white adipose tissue of the epididymis to the efferent activity of the sympathetic and vagus nerve in the rat. Neurosci Lett\u2008262:125\u2013128, 1999","DOI":"10.1016\/S0304-3940(99)00054-3"},{"key":"2022031223301495300_R14","doi-asserted-by":"crossref","unstructured":"Tanida M, Iwashita S, Ootsuka Y, Terui N, Suzuki M: Leptin injection into white adipose tissue elevates renal sympathetic nerve activity dose-dependently through the afferent nerves pathway in rats. Neurosci Lett\u2008293:107\u2013110, 2000","DOI":"10.1016\/S0304-3940(00)01490-7"},{"key":"2022031223301495300_R15","doi-asserted-by":"crossref","unstructured":"DiBona GF, Kopp UC: Neural control of renal function. Physiol Rev\u200877:75\u2013197, 1997","DOI":"10.1152\/physrev.1997.77.1.75"},{"key":"2022031223301495300_R16","doi-asserted-by":"crossref","unstructured":"Haynes WG, Morgan DA, Djalali A, Sivitz WI, Mark AL: Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension\u200833:542\u2013547, 1999","DOI":"10.1161\/01.HYP.33.1.542"},{"key":"2022031223301495300_R17","doi-asserted-by":"crossref","unstructured":"Satoh N, Ogawa Y, Katsuura G, Numata Y, Masuzaki H, Yoshimasa Y, Nakao K: Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system. Neurosci Lett\u2008249:107\u2013110, 1998","DOI":"10.1016\/S0304-3940(98)00401-7"},{"key":"2022031223301495300_R18","doi-asserted-by":"crossref","unstructured":"Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF: Serum immunoreactive leptin concentrations in normal-weight and obese humans. N Engl J Med\u2008334:292\u2013295, 1996","DOI":"10.1056\/NEJM199602013340503"},{"key":"2022031223301495300_R19","doi-asserted-by":"crossref","unstructured":"Scherrer U, Randin D, Tappy L, Vollenweider D, Jequier E, Nicod P: Body fat and sympathetic nerve activity in healthy subjects. Circulation\u200889:2634\u20132640, 1994","DOI":"10.1161\/01.CIR.89.6.2634"},{"key":"2022031223301495300_R20","doi-asserted-by":"crossref","unstructured":"Grassi G, Seravalle G, Cattaneo BM, Bolla GB, Lanfranchi A, Colombo M, Giannattasio C, Brunani A, Cavagnini F, Mancia G: Sympathetic activation in obese normotensive subjects. Hypertension\u200825:560\u2013563, 1995","DOI":"10.1161\/01.HYP.25.4.560"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/51\/2\/439\/644027\/db0202000439.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/51\/2\/439\/644027\/db0202000439.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:12:18Z","timestamp":1667405538000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/51\/2\/439\/34411\/The-Concept-of-Selective-Leptin-ResistanceEvidence"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2,1]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,2,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diabetes.51.2.439","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,2,1]]}}}